Notice for Ruxuplam (Skyhawk Therapeutics Australia Pty Ltd)
Active ingredients
Ruxuplam
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
enteric-coated tablet
Indication
Huntington's Disease
Therapeutic area
Neurology